This Article Full Text Full Text (PDF) Supplementary Data Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Desai, S. J. Articles by Kung, H.-J. Search for Related Content PubMed PubMed Citation Articles by Desai, S. J. Articles by Kung, H.-J.

Inappropriate Activation of the Androgen Receptor by Nonsteroids: Involvement of the Src Kinase Pathway and Its Therapeutic Implications

Department of Biological Chemistry and Cancer Center, University of California at Davis, Sacramento, California

Requests for reprints: Hsing-Jien Kung, UC Davis Cancer Center, University of California-Davis Medical Center, Research III, Room 2400B, 4645 2nd Avenue, Sacramento, CA 95817. Phone: 916-734-1538; Fax: 916-734-2589; E-mail: hkung{at}ucdavis.edu.

The inappropriate activation of androgen receptor (AR) by nonsteroids is considered a potential mechanism in the emergence of hormone-refractory prostate tumors, but little is known about the properties of these "pseudoactivated" AR. Here, we present the first comprehensive analysis closely examining the properties of AR activated by the neuropeptide bombesin that distinguish it from androgen-activated AR. We show that bombesin-activated AR (a) is required for bombesin-induced growth of LNCaP cells, (b) has a transcriptional profile overlapping with, but not identical to, androgen-activated AR, (c) activates prostate-specific antigen by preferentially binding to its proximal promoter, and (d) assembles a distinct coactivator complex. Significantly, we found that Src kinase is critical for bombesin-induced AR-mediated activity and is required for translocation and transactivation of AR. Additionally, we identify c-Myc, a Src target gene, to be activated by bombesin and a potential coactivator of AR-mediated activity specific to bombesin-induced signaling. Because Src kinase is often activated by other nonsteroids, such as other neuropeptides, growth factors, chemokines, and cytokines, our findings have general applicability and provide rationale for investigating the efficacy of the Src kinase pathway as a target for the prevention of relapsed prostate cancers. (Cancer Res 2006; 66(21): 10449-59)

This article has been cited by other articles:

				K. Malinowska, H. Neuwirt, I. T Cavarretta, J. Bektic, H. Steiner, H. Dietrich, P. L Moser, D. Fuchs, A. Hobisch, and Z. Culig Interleukin-6 stimulation of growth of prostate cancer in vitro and in vivo through activation of the androgen receptor Endocr. Relat. Cancer, March 1, 2009; 16(1): 155 - 169. [Abstract] [Full Text] [PDF]

				R. H. Kim, J. M. Coates, T. L. Bowles, G. P. McNerney, J. Sutcliffe, J. U. Jung, R. Gandour-Edwards, F. Y.S. Chuang, R. J. Bold, and H.-J. Kung Arginine Deiminase as a Novel Therapy for Prostate Cancer Induces Autophagy and Caspase-Independent Apoptosis Cancer Res., January 15, 2009; 69(2): 700 - 708. [Abstract] [Full Text] [PDF]

				J. C. Yang, J.-h. Ok, J. E. Busby, A. D. Borowsky, H.-J. Kung, and C. P. Evans Aberrant Activation of Androgen Receptor in a New Neuropeptide-Autocrine Model of Androgen-Insensitive Prostate Cancer Cancer Res., January 1, 2009; 69(1): 151 - 160. [Abstract] [Full Text] [PDF]